The impact of vitamin and mineral supplements usage prior to COVID-19 infection on disease severity and hospitalization

Authors

  • Refat M. Nimer Department of Medical Laboratory Sciences, Jordan University of Science and Technology, Irbid, Jordan https://orcid.org/0000-0002-0545-3311
  • Omar F. Khabour Department of Medical Laboratory Sciences, Jordan University of Science and Technology, Irbid, Jordan https://orcid.org/0000-0002-3006-3104
  • Samer F. Swedan Department of Medical Laboratory Sciences, Jordan University of Science and Technology, Irbid, Jordan https://orcid.org/0000-0002-2847-9397
  • Hassan M. Kofahi Department of Medical Laboratory Sciences, Jordan University of Science and Technology, Irbid, Jordan https://orcid.org/0000-0002-4905-7492

DOI:

https://doi.org/10.17305/bjbms.2021.7009

Keywords:

COVID-19, supplements, vitamin D, hospitalization, severity

Abstract

The COVID-19 pandemic has caused a global public health emergency. Nutritional status is suggested to be related to the severity of COVID-19 infection. Herein, we aimed to explore the impact of using vitamin and mineral supplements prior to COVID-19 infection on disease severity and hospitalization. In addition, the prior use of aspirin as an anticoagulant on the disease severity was investigated. A cross-sectional, self-administered survey was conducted between March and July 2021. Recovered COVID-19 individuals (age ≥ 18 years, n = 2148) were recruited in the study. A multivariate logistic regression was used to evaluate the associations of supplements and aspirin use with COVID-19 disease severity and hospitalization status. Among the participants, 12.1% reported symptoms consistent with severe COVID-19, and 10.2% were hospitalized due to COVID-19. After adjustment for confounding variables (age, gender, BMI, cigarette smoking status, and the number of comorbidities), the multivariate logistic regression model showed that the consumption of vitamin D supplements prior to COVID-19 infection was associated with a significant decrease in disease severity (OR = 0.68, 95% CI 0.50 - 0.92; P = 0.01), and a lower risk of hospitalization (OR = 0.64, 95% CI 0.45 - 0.89; P = 0.01). On the other hand, there were no significant differences in the frequencies of severe illness and hospitalizations with the consumption of vitamin A, folic acid, vitamin B12, vitamin B complex, vitamin C, zinc, iron, selenium, calcium, magnesium, omega 3, and aspirin before COVID-19 infection. Among the investigated nutrients, the use of vitamin D prior to COVID-19 infection was associated with reduced disease severity and hospitalization. However, more studies are required to confirm this finding.

Downloads

Download data is not yet available.
The impact of vitamin and mineral supplements usage prior to COVID-19 infection on disease severity and hospitalization

Downloads

Additional Files

Published

2022-09-16

How to Cite

1.
Nimer RM, Khabour OF, Swedan SF, Kofahi HM. The impact of vitamin and mineral supplements usage prior to COVID-19 infection on disease severity and hospitalization. Biomol Biomed [Internet]. 2022Sep.16 [cited 2023Jun.2];22(5):826-32. Available from: https://www.bjbms.org/ojs/index.php/bjbms/article/view/7009

Issue

Vol. 22 No. 5 (2022)

Section

New and Emerging Medical Entities

License

Copyright (c) 2022 Refat Nimer, Omar Khabour, Samer Swedan, Hassan Kofahi

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

INTRODUCTION

The coronavirus disease 2019 (COVID-19) is a worldwide pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [1,2]. According to the WHO, a total of 271,963,258 COVID-19 cases and 5,331,019 deaths were reported as of December 17th, 2021 [3]. SARS-CoV-2 infection is associated with a broad spectrum of symptoms ranging from moderate to severe pneumonia, coagulopathy, and death [4]. The percentage of severe cases requiring hospitalization varies from country to country but is estimated to account for 10-20% of all SARS-CoV-2 infections globally [5,6].

Dietary immunomodulators are substances that affect the functions of the immune system. Examples include vitamins A, C, D, E, and beta-carotene, as well as microelements such as zinc, selenium, and omega-3 fatty acids [7,8]. These substances are essential for acquired and innate immunity mediated by neutrophils, macrophages, natural killer cells, and T lymphocytes [7,9,10]. Therefore, deficiency in dietary immunomodulators could increase the risk of severe COVID-19 infection [11]. Such deficiencies can be corrected by following a healthy diet combined with the proper use of supplements. Although the use of vitamin and mineral supplements does not prevent infection with COVID-19 [12], it can improve immune status and subsequent disease severity [13,14]. Hence, the use of supplements has increased drastically during the COVID-19 pandemic [15].

Since COVID-19 has been shown to cause blood clotting, the use of aspirin has increased during the pandemic to overcome such complications. In addition to preventing clotting, aspirin reduces blood levels of interleukin-6 (IL-6), C-reactive protein, and macrophage colony-stimulating factor [16]. Therefore, aspirin use may help in reducing the occurrence of COVID-19-induced thrombosis and cytokine storm [17].

Several studies have reported the benefits of using vitamin and mineral supplements following a diagnosis of COVID-19 to improve the clinical course of the disease [18-21]. However, the benefits of regular intake of supplements before COVID-19 infection on the clinical course remain undefined. The study aimed to investigate the effect of regular use of supplements and aspirin before COVID-19 infection on disease severity and hospitalization status. We hypothesize that using some of these dietary supplements would be associated with reduced disease severity and fewer hospitalizations.

MATERIALS AND METHODS

Study design and participants

This study is part of the Jordanian COVID-19 survey project (JCSP). Ethical approval for the project was obtained from the institutional review board of Jordan University of Science and Technology (Ref.: 3/139/2021, dated: 30/03/2021). This cross-sectional study was conducted in Jordan between March and July 2021. The target population were individuals (≥18-years-old) who recovered from COVID-19 disease. The exclusion criteria included current COVID-19 infections and pre-infection vaccination status. Subjects who had been vaccinated prior to infection were excluded because vaccination strongly influences disease severity and thus may obliterate any effect that could be observed when supplementation was used.

The study instrument

The study utilized a self-administered questionnaire in the Arabic language. The questionnaire collected information from participants on their demographics (such as age, gender, body mass index [BMI], and education), comorbidities, consumption of supplements (vitamins and minerals), and aspirin use prior to infection. In addition, information about disease symptoms and hospitalization status was collected. The questionnaire was face validated by a group of experts in the field and was piloted on a small sample of the population. Comments were obtained from experts and participants and were used to review and improve the clarity of the questionnaire. Data from the pilot study were not included in the final analyses.

Sampling procedure

The study followed a convenient sampling procedure. The questionnaire was prepared and administered using Google forms. To ensure anonymity, identifying information such as participants’ names and places of work were not collected. The first part of the questionnaire obtained informed consent and confirmed recovery from COVID-19. To ensure that the Jordanian population is well represented, trained research assistants recruited participants from different Jordanian governorates and assisted the participants in filling out the questionnaire. A total of 2148 participants completed the questionnaire.

COVID-19 severity classification

Disease symptoms were utilized to classify COVID-19 into two categories as previously reported [22]; severe and non-severe (asymptomatic, mild symptoms, and moderate). Mild cases included fever, sore throat, malaise, body pains, nausea, and other symptoms, but no signs or symptoms of pneumonia. Moderate cases included pneumonia (persistent fever and cough) but no hypoxemia (SpO2 ≤ 92%). Severe cases were assigned to those with verified severe pneumonia and hypoxemia [22]. It is worth noting that some severe cases were not admitted to hospitals, which may be due to hospital overcrowding during the peak waves of the COVID-19. Therefore, such cases obtained medical care at home via private doctor visits, and some used medical oxygen supply systems at their homes.

Statistical analysis

The independent variables in the study were the use of supplements and aspirin. The dependent variables were COVID-19 severity and hospitalization. Frequencies and percentages were used for categorical variables. Means and standard deviations (SD) were used for continuous variables. The Chi-square was used to test differences in the severity/hospitalization between supplement/aspirin usage groups. Multivariate logistic regression analysis was used to explore the effect of supplement/aspirin usage on the severity/hospitalization after adjustment for possible confounders (age, gender, BMI, cigarette smoking, and number of comorbidities). The adjusted odds ratios (OR) and 95% confidence intervals (CI) were reported for each independent variable. A p < 0.05 was considered significant. The data were analyzed using the Statistical Package for the Social Sciences version 23 (IBM Inc., Armonk, New York, United States).

RESULTS

Characteristics of study participants

Overall, 2148 individuals participated in the study. Table 1 summarizes participants’ characteristics. Females represented 58.2% of the study population. The mean age ± SD of the participants was 40 ± 16 years. Among the participants, 12.1% reported symptoms consistent with severe COVID-19, 10.2% were admitted to the hospital due to COVID-19, 23.1% had at least one comorbidity, and 16.9% were current cigarette smokers (Table 1).

TABLE 1: Baseline characteristics of the participants

Association of supplements and aspirin use with COVID-19 severity and hospitalization

The effects of supplements or aspirin use on the frequencies of COVID-19 severe cases and hospitalizations were investigated (Table 2). Among the supplements included in our study, consumption of vitamin D prior to COVID-19 infection was significantly associated with decreased frequencies of severe illness (p = 0.04) and hospitalization (p = 0.03). In addition, the rate of hospitalization was significantly decreased among the participants who consumed vitamin C before COVID-19 infection (p = 0.03). Vitamin C consumption was also associated with reduced disease severity. However, the difference did not reach statistical significance (p = 0.07). Moreover, a significantly higher frequency of severe illness and/or hospitalization was observed among participants who consumed selenium, omega 3, vitamin B complex, calcium, and magnesium supplements, and aspirin before COVID-19 infection (Table 2). On the other hand, there were no significant differences in the frequencies of severe illness and hospitalizations with the consumption of vitamin A, folic acid, vitamin B12, multivitamins, zinc, and iron before COVID-19 infection.

TABLE 2: Severe COVID-19 and hospitalization cases according to use of supplements and substances prior to infection

Logistic regression analyses

Next, to verify the associations above, we performed multivariate logistic regression analyses to control for the possible confounders such as age, gender, BMI, cigarette smoking, and the number of comorbidities. The ORs and 95% CI for the two outcomes, COVID-19 severity, and hospitalization status with the use of each supplement/aspirin, are presented in Table 3. The results of this model demonstrated that after adjusting for the confounders, vitamin D consumption was the only predictive factor to associate with lower risk of COVID-19 severity (OR = 0.68, 95% CI 0.50-0.92; p = 0.01, Table 3), and lower percentage of hospitalizations (OR = 0.63, 95% CI 0.45-0.89; p = 0.01, Table 3).

TABLE 3: Logistic regression analyses for supplements and aspirin use with COVID-19 severity and hospitalization as the output

DISCUSSION

In this study, we investigated the impact of using vitamin and mineral supplements and aspirin prior to infection with COVID-19 on disease severity and hospitalization. Previous studies and clinical trials have focused on the impact of using vitamins and minerals during the infection on COVID-19 outcomes [14,23,24]. These studies reported significant effects of several vitamins and trace elements on reducing disease severity [25-27]. However, using these supplements prior to COVID-19 infection can give a powerful boost to the immune system. This increases its effectiveness in the early stages of the disease and could be crucial in determining disease outcome.

In a large survey of 349,598 participants in the UK, vitamin D levels were negatively associated with the probability of COVID-19 infection. After adjusting for confounders in multivariable analyses, this connection was not maintained [28]. In contrast, a large cohort study (n = 108,343) in Spain showed that people with serum vitamin D levels ≥ 30 ng/mL were more likely to have better COVID-19 outcomes after adjusting for outcome variables [29]. In our study, univariate analysis indicated associations between vitamin D and vitamin C consumption and reduced disease COVID-19 severity and hospitalization. However, using regression analysis to adjust for possible confounding factors, only vitamin D consumption was predicted to decrease the risk of severe disease and hospitalization. This indicates that confounding factors likely affected the observed association for vitamin C. Hemilä et al. reported that routine vitamin C supplementation is not justified and fails to reduce the incidence of colds and other respiratory infections [30]. Our findings are consistent with Demir et al., who showed that high vitamin D levels might reduce COVID-19 hospital stay and disease severity [31]. Lower vitamin D levels in COVID-19 patients compared to uninfected individuals were reported previously, suggesting a link between inadequate vitamin D levels and susceptibility to infection [32,33]. In addition, increased infection, hospitalization, and death from COVID-19 have been associated with low vitamin D levels [34-36]. Vitamin D has also been shown to increase the production of anti-inflammatory cytokines, such as IL-10, which is predicted to lower the severity of COVID-19 [37], and improve the activity of macrophages and T lymphocytes [38].

With the exception of vitamin D, adequate amounts of vitamins are obtained through the diet in most individuals [39,40]. However, according to US National Health and Nutrition Examination Survey (NHANES), about half of the respondents (n = 6,261) did not get sufficient vitamin D from food alone, including fortified products [41]. In addition, individuals with darker skin produce less vitamin D than those with lighter skin upon sun exposure [42]. Thus, vitamin D supplementation is necessary for maintaining optimal vitamin D levels. In agreement with our results, a meta-analysis of 25 studies with 11,321 participants in total found that vitamin D supplementation significantly reduced the risk of acute respiratory tract infections [43]. Furthermore, a meta-analysis conducted by Martineau et al. reported that vitamin D supplementation is associated with protection against acute respiratory infections [43]. Therefore, vitamin D supplementation is recommended during the infection with COVID-19, as well as before the infection as a preventative measure [44].

A significantly higher frequency of severe illness and hospitalization was observed among selenium users, omega 3, vitamin B complex, calcium and magnesium supplements, and aspirin. However, none of these supplements were predicted to increase the risk of severity/hospitalization in the logistic regression analyses. This discrepancy can be explained by regular usage of these supplements/aspirin is more frequent among individuals with a higher risk for severe illness such as the elderly and those with pre-existing medical conditions [45,46]. Therefore, controlling for these confounding factors is essential to demonstrate true associations between vitamins, minerals, and aspirin and either disease severity or hospitalization status. Consistent with this conclusion, aspirin intake was not associated with COVID-19-related complications and mortality [47]. Currently, there is no direct evidence to indicate that omega-3 helps in the defense against COVID-19 [48].

Furthermore, logistic regression analysis indicated no association between B vitamins, calcium, and magnesium intake and COVID-19 severity. It is known that B vitamins regulate chemokine and cytokine production and mediate the interplay between immune cells involved in pathological processes [49]. However, the role of B vitamins in reducing COVID-19 severity is highly controversial [50,51]. Similarly, the role of calcium and magnesium body status in COVID-19 manifestations is still controversial [52-54]. It is important to note that the use of supplements such as selenium, vitamin A, and folic acid was too low among the study participants. Therefore, more studies are needed to confirm the present findings.

Although this study assessed the impact of using aspirin and supplements prior to COVID-19 infection on disease severity and hospitalization based on a relatively large sample, it had some limitations. This was a cross-sectional study conducted using an anonymous questionnaire. The findings given were largely self-reported and were dependent on the participants’ reliability, honesty, and recallability. It is likely that some participants answered the questions in a way that they believed was objectively appropriate and not entirely correct. Some participants gave extreme responses based on their personal beliefs introducing so response biases.

Previous literature has shown that the severity of COVID-19 is elevated among the elderly, malnourished individuals, and those with high BMI or comorbidities [55-57]. Therefore, a regression analysis was applied to control for potential confounding factors in the current study. However, it is recommended that the relationship between supplement use and severity be examined in each subgroup with adequate samples in future studies. Among the limitations of the current investigation is that the study did not collect information regarding duration of illness and time of hospitalization. Therefore, the study could not examine the effect of supplement use on such measures. This could be the subject of future investigations. Furthermore, each participant’s rate of supplementary support during the infection was not equal. Furthermore, the levels of supplements and minerals used by the patients were unknown. Finally, since the study is questionnaire-based, fatal cases (that represent the highest severity) could not be included. Thus, more clinical studies are needed to confirm the present findings we are proposing within this study.

CONCLUSION

Our findings showed that vitamin D supplementation has protective effects against the severity and hospitalization of COVID-19 infection. Therefore, during this pandemic, persons at increased risk of vitamin D insufficiency should consider taking vitamin D supplements to maintain circulating vitamin D at an optimum range.

Acknowledgements

ACKOWLEDGMENTS

The authors would like to acknowledge the deanship of research at Jordan University of Science and Technology for funding this project (grant number 20210173).

REFERENCES

  1. , , , , , (). A novel coronavirus from patients with pneumonia in China,2019. N Engl J Med. https://doi.org/10.1056/NEJMoa2001017
  2. , , (). The novel Coronavirus originating in Wuhan, China:Challenges for global health governance. JAMA. https://doi.org/10.1001/jama.2020.1097
  3. (). . WHO Coronavirus (COVID-19) Dashboard 2021. Available from: https:// covid19.who.int
  4. , , , , (). Pathophysiology, transmission, diagnosis, and treatment of Coronavirus disease 2019 (COVID-19):A review. Jama. https://doi.org/10.1001/jama.2020.12839
  5. , , , , , (). Estimates of the severity of Coronavirus disease 2019:A model-based analysis. Lancet Infect Dis. https://doi.org/10.1016/S1473-3099(20)30243-7
  6. , , , , , (). Features of 20 133 aUK patients in hospital with COVID-19 using the ISARIC WHO clinical characterisation protocol:Prospective observational cohort study . BMJ. https://doi.org/10.1136/bmj.m1985
  7. , , , (). Potential immunomodulatory effects from consumption of nutrients in whole foods and supplements on the frequency and course of infection:Preliminary results. Nutrients. https://doi.org/10.3390/nu13041157
  8. , (). The role of Vitamin C, Vitamin D, and selenium in immune system against COVID-19. aMolecules.
  9. , , , , , (). Toward improved human health:Efficacy of dietary selenium on immunity at the cellular level. Food Funct. https://doi.org/10.1039/d0fo03067h
  10. , , (). Selenium in the immune system. J Nutr. https://doi.org/10.1093/jn/133.5.1457S
  11. , , , , , (). Nutritional status of patients with COVID-19. aInt J Infect Dis. https://doi.org/10.1016/j.ijid.2020.08.018
  12. , , (). Vitamins, supplements and COVID-19:A review of currently available evidence. Drugs Context. https://doi.org/10.7573/dic.2021-6-2
  13. , , , , , (). Role of vitamins and minerals as immunity boosters in COVID-19.. aInflammopharmacology. https://doi.org/10.1007/s10787-021-00826-7
  14. , , , , , (). The correlation between serum selenium, zinc, and COVID-19 aseverity:An observational study . BMC Infect Dis. https://doi.org/10.1186/s12879-021-06617-3
  15. , (). Dramatic increase in dietary supplement use during COVID-19. aCurr Dev Nutr. https://doi.org/10.1093/cdn/nzab029_008
  16. , , , , , (). COVID-19:Consider cytokine storm syndromes and immunosuppression. Lancet. https://doi.org/10.1016/S0140-6736(20)30628-0
  17. , , , , , , (). Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19:An updated analysis. Thromb Res. https://doi.org/10.1016/j.thromres.2020.04.041
  18. , , , , , (). Be well:A potential role for Vitamin B in COVID-19. aMaturitas. https://doi.org/10.1016/j.maturitas.2020.08.007
  19. , , , , (). asconcelos Torres G.Vitamin C and D supplementation and the severity of COVID-19:A protocol for systematic review and meta-analysis. Medicine (Baltimore). https://doi.org/10.1097/MD.0000000000026427
  20. , , (). The potential impact of zinc supplementation on COVID-19 apathogenesis . Front Immunol. https://doi.org/10.3389/fimmu.2020.01712
  21. , , , , (). The effects of aspirin on the outcome of COVID-19:A systematic review and meta-analysis. Clin Epidemiol Glob Health. https://doi.org/10.1016/j.cegh.2021.100883
  22. (). COVID-19:Current understanding of its pathophysiology, clinical presentation and treatment. Postgrad Med J. https://doi.org/10.1136/postgradmedj-2020-13ↁ
  23. , (). The effect of high-dose parenteral Vitamin D3 aon COVID-19-related inhospital mortality in critical COVID-19 patients during intensive care unit admission:An observational cohort study . Eur J Clin Nutr. https://doi.org/10.1038/s41430-021-00984-5
  24. , , , , , (). Ascorbic acid as an adjunctive therapy in critically ill patients with COVID-19:A propensity score matched study. Sci Rep. https://doi.org/10.1038/s41598-021-96703-y
  25. (). Zinc against COVID-19?Symptom surveillance and deficiency risk groups. PLoS Negl Trop Dis. https://doi.org/10.1371/journal.pntd.0008895
  26. , , , , , (). Early nutritional interventions with Zinc, selenium and Vitamin D for raising anti-viral resistance against progressive COVID-19. aNutrients. https://doi.org/10.3390/nu12082358
  27. , , , , , (). Selenium deficiency is associated with mortality risk from COVID-19. Nutrients. https://doi.org/10.3390/nu12072098
  28. , , , , , (). Vitamin D concentrations and COVID-19 ainfection in UK Biobank. Diabetes Metab Syndr. https://doi.org/10.1016/j.dsx.2020.04.050
  29. , , , , , (). Vitamin D supplementation and COVID-19 arisk:A population-based, cohort study . J Endocrinol Invest. https://doi.org/10.1007/s40618-021-01639-9
  30. , (). Vitamin C for preventing and treating the common cold. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858
  31. , , (). Vitamin D deficiency is associated with COVID-19 apositivity and severity of the disease . J Med Virol. https://doi.org/10.1002/jmv.26832
  32. , , , , (). SARS-CoV-2 apositivity rates associated with circulating 25-hydroxyvitamin D levels. PLoS One. https://doi.org/10.1371/journal.pone.0239252
  33. , , , , , (). Association of Vitamin D status and other clinical characteristics with COVID-19 atest results . JAMA Netw Open. https://doi.org/10.1001/jamanetworkopen.2020.19722
  34. , , , , (). Serum 25(OH)D level on hospital admission associated with COVID-19 astage and mortality. Am J Clin Pathol. https://doi.org/10.1093/ajcp/aqaa252
  35. , , (). Increased risk for COVID-19 ain patients with Vitamin D deficiency . Nutrition. https://doi.org/10.1016/j.nut.2020.111106
  36. , , , , , (). Association of Vitamin D status and COVID-19-related hospitalization and mortality. J Gen Intern Med. https://doi.org/10.1007/s11606-021-07170-0
  37. , , , , , (). An autocrine Vitamin D-driven Th1 ashutdown program can be exploited for COVID-19 . bioRxiv. https://doi.org/10.1101/2020.07.18.210161
  38. , , , (). Vitamin D3:A helpful immuno-modulator. Immunology. https://doi.org/10.1111/j.1365-2567.2011.03482.iax
  39. , , , , , (). Dietary reference intakes for Vitamin A, Vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. eIn:A Report of the Panel on Micronutrients, Subcommittees on Upper Reference Levels of Nutrients and of Interpretation and Uses of Dietary Reference Intakes, and the Standing Committee on the Scientific Evaluation of Dietary Reference Intakes Food and Nutrition Board Institute of Medicine.
  40. , (). Is Vitamin D deficiency a major global public health problem?. J Steroid Biochem Mol Biol. https://doi.org/10.1016/j.jsbmb.2013.11.003
  41. , , (). The prevalence and determinants of Vitamin D inadequacy among U.S. older adults:National health and nutrition examination survey 2007-2014. Cureus. https://doi.org/10.7759/cureus.5300
  42. , , (). Photoprotection and Vitamin D status. J Photochem Photobiol B. https://doi.org/10.1016/j.jphotobiol.2010.03.006
  43. , , , , , (). Vitamin D supplementation to prevent acute respiratory tract infections:Systematic review and meta-analysis of individual participant data. BMJ. https://doi.org/10.1136/bmj.i6583
  44. , , , , , (). COVID-19 aseverity in relation to sociodemographics and Vitamin D use . Open Med (Wars). https://doi.org/10.1515/med-2021-0273
  45. , , , , , (). Effects of Vitamin D in the elderly population:Current status and perspectives. Arch Public Health. https://doi.org/10.1186/2049-3258-72-32
  46. , , , , , (). Benefits of vitamins in the treatment of Parkinson's disease. Oxid Med Cell Longev. https://doi.org/10.1155/2019/9426867
  47. , , , , , (). Effect of aspirin on Coronavirus disease 2019:A nationwide case-control study in South Korea. Medicine (Baltimore). https://doi.org/10.1097/MD.0000000000026670
  48. , , , (). Can N-3 apolyunsaturated fatty acids be considered a potential adjuvant therapy for COVID-19-associated cardiovascular complications?. Pharmacol Ther. https://doi.org/10.1016/j.pharmthera.2020.107703
  49. , , , (). Vitamin B 6 asupplementation improves pro-inflammatory responses in patients with rheumatoid arthritis . Eur J Clin Nutr. https://doi.org/10.1038/ejcn.2010.107
  50. , , , , , (). Cohort study to evaluate the effect of Vitamin D, magnesium, and Vitamin B(12) in combination on progression to severe outcomes in older patients with coronavirus (COVID-19). Nutrition. https://doi.org/10.1016/j.nut.2020.111017
  51. (). COVID-19's toll on the elderly and those with diabetes mellitus-is Vitamin B12 adeficiency an accomplice?. Med Hypotheses. https://doi.org/10.1016/j.mehy.2020.110374
  52. , (). Conflicts over calcium and the treatment of COVID-19. Evol Med Public Health. https://doi.org/10.1093/emph/eoaa046
  53. , , , , (). Nutritional approach for increasing public health during pandemic of COVID-19:A comprehensive review of antiviral nutrients and nutraceuticals. Health Promot Perspect. https://doi.org/10.34172/hpp.p2021.17
  54. , , (). Keeping a balance during the pandemic:A narrative review on the important role of micronutrients in preventing infection and reducing complications of COVID-19. Curr Nutr Rep. https://doi.org/10.1007/s13668-021-00356-2
  55. , , , , , (). Nutritional status is closely related to the severity of COVID-19:A multi-center retrospective study. J Infect Dev Ctries. https://doi.org/10.3855/jidc.14178
  56. , , , , (). Obesity and mortality of COVID-19. aMeta-analysis. Obes Res Clin Pract. https://doi.org/10.1016/j.orcp.2020.07.002
  57. , (). Biomarkers of biological age as predictors of COVID-19 adisease severity . Aging (Albany NY). https://doi.org/10.18632/aging.103052

Conflict of interests: Authors declare no conflict of interests.

Funding: This study is supported by the deanship of research at Jordan University of Science and Technology (grant number 20210173).